Top compounds associated with response to CYP46A1


Feature Type Standardized
Nominal ANOVA
mRNA MLN2480 CTRPv2 pan-cancer AAC -0.02 0.7
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.012 0.7
mRNA Vorinostat GDSC1000 pan-cancer AAC 0.012 0.7
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC 0.013 0.7
mRNA BAY 61-3606 GDSC1000 pan-cancer AAC 0.013 0.7
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.013 0.7
mRNA Vorinostat FIMM pan-cancer AAC 0.062 0.7
mRNA lenalidomide FIMM pan-cancer AAC -0.065 0.7
mRNA SB 216763 GDSC1000 pan-cancer AAC -0.014 0.7
mRNA Crizotinib gCSI pan-cancer AAC 0.02 0.7
Download CSV